Close Menu

NEW YORK ─ A wide swath of companies in the healthcare sector have banded together to form the COVID-19 Testing Industry Consortium to accelerate aspects of SARS-CoV-2 testing, including research and clinical diagnostic applications, Bristol Myers Squibb (BMS) said Thursday.

Nineteen organizations, organized and led by BMS, will seek to accelerate research through enhanced collaboration and information sharing with the ultimate goal of improving COVID-19 testing globally.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.